Prevalence and risk factors of non-alcoholic fatty liver disease in potential living liver donors in Korea: a review of 589 consecutive liver biopsies in a single center.
暂无分享,去创建一个
E. Yu | H. Lee | Y. Chung | K. Kim | Y. Lim | Ji Young Lee | Y. Lee | D. Suh | Sung Gyu Lee
[1] J. Ludwig,et al. Hepatic steatosis as a potential risk factor for major hepatic resection , 1998, Journal of Gastrointestinal Surgery.
[2] K. Sung,et al. Lessons learned from 1,000 living donor liver transplantations in a single center: How to make living donations safe , 2006, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[3] Shi-yao Chen,et al. Prevalence of and risk factors for fatty liver in a general population of Shanghai, China. , 2005, Journal of hepatology.
[4] O. Cummings,et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease , 2005, Hepatology.
[5] M. Manos,et al. Racial and ethnic distribution of nonalcoholic fatty liver in persons with newly diagnosed chronic liver disease , 2005, Hepatology.
[6] A. Sanyal,et al. The histologic spectrum of nonalcoholic fatty liver disease. , 2004, Clinics in liver disease.
[7] L. Bolondi,et al. Increased prevalence of fatty liver in arterial hypertensive patients with normal liver enzymes: role of insulin resistance , 2004, Gut.
[8] S. Jang,et al. The effect of donor weight reduction on hepatic steatosis for living donor liver transplantation , 2004, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[9] C. Rosen,et al. Evaluation of the donor liver for living donor liver transplantation , 2003, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[10] R. Fisher,et al. Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values , 2003, Hepatology.
[11] S. Strasser,et al. Clinical experience gained from the use of 120 steatotic donor livers for orthotopic liver transplantation , 2003, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[12] G. Marchesini,et al. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome , 2003, Hepatology.
[13] C. Ryan,et al. One hundred consecutive hepatic biopsies in the workup of living donors for right lobe liver transplantation , 2002, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[14] Erick M Remer,et al. The utility of radiological imaging in nonalcoholic fatty liver disease. , 2002, Gastroenterology.
[15] Mauro Salizzoni,et al. Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma. , 2002, Gastroenterology.
[16] P. Giral,et al. Survival, liver failure, and hepatocellular carcinoma in obesity‐related cryptogenic cirrhosis , 2002, Hepatology.
[17] G. Pacini,et al. Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: Further evidence for an etiologic association , 2002, Hepatology.
[18] D. Allison,et al. Larger amounts of visceral adipose tissue in Asian Americans. , 2001, Obesity research.
[19] M. Graif,et al. Quantitative estimation of attenuation in ultrasound video images: correlation with histology in diffuse liver disease. , 2000, Investigative radiology.
[20] R. Fisher,et al. Liver regeneration and function in donor and recipient after right lobe adult to adult living donor liver transplantation. , 2000, Transplantation.
[21] G. Brandi,et al. Prevalence of and Risk Factors for Hepatic Steatosis in Northern Italy , 2000, Annals of Internal Medicine.
[22] L. Castéra,et al. Pain experienced during percutaneous liver biopsy , 1999, Hepatology.
[23] G. Marchesini,et al. Association of nonalcoholic fatty liver disease with insulin resistance. , 1999, The American journal of medicine.
[24] B. Neuschwander‐Tetri,et al. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions , 1999, American Journal of Gastroenterology.
[25] S. Thung,et al. The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 1999 by The Endocrine Society Liver Pathology and the Metabolic Syndrome X in , 2022 .
[26] K. Batts,et al. Use of fatty donor liver is associated with diminished early patient and graft survival. , 1996, Transplantation.
[27] A. Burroughs,et al. Indications, methods, and outcomes of percutaneous liver biopsy in England and Wales: an audit by the British Society of Gastroenterology and the Royal College of Physicians of London. , 1995, Gut.
[28] B. Neuschwander‐Tetri,et al. Nonalcoholic steatohepatitis: an expanded clinical entity. , 1994, Gastroenterology.
[29] S Burastero,et al. Asians have lower body mass index (BMI) but higher percent body fat than do whites: comparisons of anthropometric measurements. , 1994, The American journal of clinical nutrition.
[30] F. Al-Mulhim,et al. Fatty infiltration of the liver: analysis of prevalence, radiological and clinical features and influence on patient management. , 1992, The British journal of radiology.
[31] I. Wanless,et al. Fatty liver hepatitis (steatohepatitis) and obesity: An autopsy study with analysis of risk factors , 1990, Hepatology.
[32] K. Ishak,et al. Alcohollike liver disease in nonalcoholics. A clinical and histologic comparison with alcohol-induced liver injury. , 1988, Gastroenterology.
[33] J. Ludwig,et al. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. , 1980, Mayo Clinic proceedings.